Literature DB >> 27170292

Expression, Purification, Crystallisation and X-ray Crystallographic Analysis of a Truncated Form of Human Src Homology 2 Containing Inositol 5-Phosphatase 2.

Johanne Le Coq1, Luis Heredia Gallego1, Daniel Lietha2.   

Abstract

The Src homology 2 containing inositol 5-phosphatase 2 (SHIP2) catalyses the dephosphorylation of the phospholipid phosphatidylinositol 3,4,5-triphosphate (PI(3,4,5)P3) to form PI(3,4)P2. PI(3,4,5)P3 is a key lipid second messenger, which can recruit signalling proteins to the plasma membrane and subsequently initiate numerous downstream signalling pathways responsible for the regulation of a plethora of cellular events such as proliferation, growth, apoptosis and cytoskeletal rearrangements. SHIP2 has been heavily implicated with several serious diseases such as cancer and type 2 diabetes but its regulation remains poorly understood. In order to gain insight into the mechanisms of SHIP2 regulation, a fragment of human SHIP2 containing the phosphatase domain and a region proposed to resemble a C2 domain was crystallized. Currently, no structural information is available on the putative C2-related domain or its relative position with respect to the phosphatase domain. Initial crystals were polycrystalline, but were optimized to obtain diffraction data to a resolution of 2.1 Å. Diffraction data analysis revealed a P212121 space group with unit cell parameters a = 136.04 Å, b = 175.84 Å, c = 176.89 Å. The Matthews coefficient is 2.54 Å(3) Da(-1) corresponding to 8 molecules in the asymmetric unit with a solvent content of 51.7 %.

Entities:  

Keywords:  C2 domain; Cell signalling; Phosphatase; Phosphatidylinositol 3,4,5-triphosphate; Src homology 2 containing inositol 5-phosphatase 2

Mesh:

Substances:

Year:  2016        PMID: 27170292     DOI: 10.1007/s10930-016-9665-y

Source DB:  PubMed          Journal:  Protein J        ISSN: 1572-3887            Impact factor:   2.371


  15 in total

Review 1.  Protein identification and analysis tools in the ExPASy server.

Authors:  M R Wilkins; E Gasteiger; A Bairoch; J C Sanchez; K L Williams; R D Appel; D F Hochstrasser
Journal:  Methods Mol Biol       Date:  1999

Review 2.  SHIP2 and its involvement in various diseases.

Authors:  Akira Suwa; Takeshi Kurama; Teruhiko Shimokawa
Journal:  Expert Opin Ther Targets       Date:  2010-07       Impact factor: 6.902

3.  Small-molecule agonists of SHIP1 inhibit the phosphoinositide 3-kinase pathway in hematopoietic cells.

Authors:  Christopher J Ong; Andrew Ming-Lum; Matt Nodwell; Ali Ghanipour; Lu Yang; David E Williams; Joseph Kim; Loutfig Demirjian; Pooran Qasimi; Jens Ruschmann; Li-Ping Cao; Kewei Ma; Stephen W Chung; Vincent Duronio; Raymond J Andersen; Gerald Krystal; Alice L-F Mui
Journal:  Blood       Date:  2007-05-14       Impact factor: 22.113

Review 4.  Enzymatic and non-enzymatic activities of SHIP-1 in signal transduction and cancer.

Authors:  Claude Condé; Geoffrey Gloire; Jacques Piette
Journal:  Biochem Pharmacol       Date:  2011-06-13       Impact factor: 5.858

5.  Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association.

Authors:  J O Lee; H Yang; M M Georgescu; A Di Cristofano; T Maehama; Y Shi; J E Dixon; P Pandolfi; N P Pavletich
Journal:  Cell       Date:  1999-10-29       Impact factor: 41.582

6.  A pleckstrin homology-related domain in SHIP1 mediates membrane localization during Fcγ receptor-induced phagocytosis.

Authors:  Andrew Ming-Lum; Shaheen Shojania; Eva So; Erin McCarrell; Eileen Shaw; David Vu; Ida Wang; Lawrence P McIntosh; Alice L-F Mui
Journal:  FASEB J       Date:  2012-05-31       Impact factor: 5.191

Review 7.  SHIP2 signalling at the plasma membrane, in the nucleus and at focal contacts.

Authors:  William's Elong Edimo; Jean-Marie Vanderwinden; Christophe Erneux
Journal:  Adv Biol Regul       Date:  2012-09-13

Review 8.  Mammalian phosphoinositide kinases and phosphatases.

Authors:  Takehiko Sasaki; Shunsuke Takasuga; Junko Sasaki; Satoshi Kofuji; Satoshi Eguchi; Masakazu Yamazaki; Akira Suzuki
Journal:  Prog Lipid Res       Date:  2009-07-04       Impact factor: 16.195

Review 9.  Scaling and assessment of data quality.

Authors:  Philip Evans
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-12-14

10.  A versatile ligation-independent cloning method suitable for high-throughput expression screening applications.

Authors:  Nick S Berrow; David Alderton; Sarah Sainsbury; Joanne Nettleship; Rene Assenberg; Nahid Rahman; David I Stuart; Raymond J Owens
Journal:  Nucleic Acids Res       Date:  2007-02-22       Impact factor: 16.971

View more
  1 in total

1.  Structural basis for interdomain communication in SHIP2 providing high phosphatase activity.

Authors:  Johanne Le Coq; Marta Camacho-Artacho; José Vicente Velázquez; Clara M Santiveri; Luis Heredia Gallego; Ramón Campos-Olivas; Nicole Dölker; Daniel Lietha
Journal:  Elife       Date:  2017-08-09       Impact factor: 8.140

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.